로딩 중…
지수 로딩 중…
Cullinan Therapeutics, Inc.
CGEM· NASDAQ· Health Care· Pharmaceuticals, Biotechnology & Life Sciences
$15.03+4.09%
2026-06-18
Price Chart
Cullinan Therapeutics, Inc.+84.19%
Financials
No data
※ FY = Fiscal Year
Investment Metrics(as of 2026-06-18)
| Metric | Value |
|---|---|
| Size | |
| Market Cap | $924M |
| Revenue | $0.00 |
| Net Income | $-221M |
| Total Assets | $403M |
| Net Assets | $366M |
| Value | |
| P/B | 2.52x |
| FCF Yield | -19.34% |
| Profitability | |
| ROE | -60.36% |
| ROA | -54.85% |
| Financial Health | |
| Debt Ratio | 10.05% |
| Total Debt | $2M |
| FCF | $-179M |
| Cash | $75M |
| Current Ratio | 10.28x |
| Performance | |
| 1Y Return | 84.19% |
| 1M Return | 5.99% |
| From 52W High | -10.22% |
| 1Y MDD | -36.67% |
| Trading | |
| Volume | 2,340,703 shares |
| Trading Value | $35M |
| Per Share | |
| EPS | $-3.71 |
| BPS | $6.90 |